Vaijayanti Pethe

Lunenfeld-Tanenbaum Research Institute — Canada

Medicine · Health Sciences

13h-index833citations53works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(28), Epigenetics and DNA Methylation(22), Cancer-related gene regulation(13), Wnt/β-catenin signaling in development and cancer(12), Colorectal Cancer Screening and Detection(5)

Publications53 total

Supplementary figure 1 from Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer
2023Open Access
Data from Correlation of ERG Expression and DNA Methylation Biomarkers with Adverse Clinicopathologic Features of Prostate Cancer
2023Open Access
Data from Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer
2023Open Access
Supplementary table 3 from Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer
2023Open Access
Supplementary table 5 from Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer
2023Open Access
Supplementary table 1 from Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer
2023Open Access
Supplementary Tables 1-6 from Correlation of ERG Expression and DNA Methylation Biomarkers with Adverse Clinicopathologic Features of Prostate Cancer
2023Open Access
Supplementary Tables 1-6 from Correlation of ERG Expression and DNA Methylation Biomarkers with Adverse Clinicopathologic Features of Prostate Cancer
2023Open Access
Supplementary Figures 1-6 from Correlation of ERG Expression and DNA Methylation Biomarkers with Adverse Clinicopathologic Features of Prostate Cancer
2023Open Access
Supplementary table 3 from Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer
2023Open Access
Data from Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer
2023Open Access
Supplementary table 1 from Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer
2023Open Access
Supplementary figure 1 from Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer
2023Open Access
Supplementary table 2 from Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer
2023Open Access
Supplementary table 5 from Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer
2023Open Access
Data from Correlation of ERG Expression and DNA Methylation Biomarkers with Adverse Clinicopathologic Features of Prostate Cancer
2023Open Access
Supplementary table 4 from Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer
2023Open Access
Supplementary table 4 from Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer
2023Open Access
Supplementary Figures 1-6 from Correlation of ERG Expression and DNA Methylation Biomarkers with Adverse Clinicopathologic Features of Prostate Cancer
2023Open Access
Supplementary table 2 from Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Bharati Bapat(46), Ken J. Kron(27), Neil Fleshner(27), Theodorus van der Kwast(27), Dominique Trudel(20), Laurent Briollais(19), Pinella Buongiorno(11), George S. Charames(11), Susmita Esufali(11), Liyang Liu(8), John Trachtenberg(8), Miralem Mrkonjic(4), Darshana Daftary(4), Stavroula Raptis(3), Elizabeth Dicks(3), Patrick S. Parfrey(3), Steve Gallinger(3), Julia A. Knight(3), Nino Demetrashvili(3), Hilmi Özçelik(3)